July 7, 2020 / 12:42 AM / a month ago

BRIEF-Tenax Therapeutics Announces $8 Mln Registered Direct And Pipe Offerings Priced At-The-Market Under Nasdaq Rules

July 6 (Reuters) - Tenax Therapeutics Inc:

* ANNOUNCES $8.0 MILLION REGISTERED DIRECT AND PIPE OFFERINGS PRICED AT-THE-MARKET UNDER NASDAQ RULES

* DEFINITIVE AGREEMENT WITH INVESTOR FOR ISSUANCE, SALE OF 2,523,611 SHARES OF COMMON STOCK AT A PURCHASE PRICE OF $1.02780/SHARE

* AGREEMENT ALSO INCLUDES PRE-FUNDED WARRANTS TO PURCHASE UP TO 652,313 SHARES OF COMMON STOCK, AT $1.02770 PER PRE-FUNDED WARRANT Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below